OKYO OKYO Pharma Ltd
Price Chart
Executive Summary
Form 3 filing by director Simon Willy Jules discloses initial beneficial ownership in OKYO Pharma Ltd, including 6,435 shares held directly and 8,948 shares held by spouse, along with multiple tranches of stock options exercisable at prices ranging from $1.46 to $2.13. This is a routine initial ownership disclosure with no material financial impact.
Actionable Insight
Routine Form 3 filing — no trading signal. Monitor for any subsequent Form 4 filings that might indicate insider buying or selling activity.
Key Facts
- Simon Willy Jules filed Form 3 as a director of OKYO Pharma Ltd on 2026-06-01, reporting ownership as of 2026-03-18.
- Direct holdings: 6,435 shares of common stock.
- Indirect holdings: 8,948 shares held by spouse.
- Options held: multiple tranches with exercise prices of $1.46, $1.50, $1.60, $1.65, and $2.13, expiring between 2033 and 2035.
- Total option shares: approximately 125,000+ across all tranches (sum of individual tranches).
Financial Impact
No financial impact; routine initial ownership disclosure.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001493152-26-026688 |
| Document: 0001493152-26-026688-index.html | 0001493152-26-026688 |
| Document: 0001493152-26-026688.txt | 0001493152-26-026688 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
10d ago
|
3
| $1.66 $1.68 | ▲ +1.20% | ▲ +0.81% | $1.52 (−8.43%) |
|
Jun 1, 2026
11d ago
|
3
| $1.70 $1.66 | ▼ −2.35% | ▼ −1.63% | $1.52 (−10.59%) |
|
Jun 1, 2026
11d ago
|
3
| $1.70 $1.66 | ▼ −2.35% | ▼ −1.63% | $1.52 (−10.59%) |
|
May 19, 2026
24d ago
|
6-K
| $1.60 $1.60 | · 0.00% | ▼ −1.04% | $1.52 (−5.00%) |
|
Apr 7, 2026
9w ago
|
6-K
| $1.60 $1.59 | ▼ −0.63% | ▼ −3.16% | $1.52 (−5.00%) |
|
Apr 7, 2026
9w ago
|
Press Release
| $1.60 $1.59 | ▼ −0.63% | ▼ −3.16% | $1.52 (−5.00%) |
|
Mar 19, 2026
12w ago
|
Press Release
| $1.62 $1.57 | ▼ −3.09% | ▼ −1.34% | $1.52 (−6.17%) |
|
Mar 19, 2026
12w ago
|
Press Release
| $1.62 $1.57 | ▼ −3.09% | ▼ −1.34% | $1.52 (−6.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access